XenoPort, Inc.
(NASDAQ : XNPT)

( )
XNPT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
-10.17%132.810.6%$1507.80m
PFEPfizer Inc.
-1.62%43.850.9%$1018.02m
MRKMerck & Co., Inc.
-2.49%76.510.6%$1010.61m
ABBVAbbVie, Inc.
-2.38%85.622.2%$531.70m
LLYEli Lilly and Company
-2.49%112.001.0%$505.80m
BMYBristol-Myers Squibb Company
-2.82%52.131.4%$488.82m
NVSNovartis AG Sponsored ADR
-1.13%87.400.2%$229.97m
AZNAstraZeneca PLC Sponsored ADR
-0.20%39.161.3%$204.11m
GSKGlaxoSmithKline plc Sponsored ADR
-0.87%37.610.2%$157.71m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.51%46.530.1%$72.80m
SNYSanofi Sponsored ADR
-1.83%44.070.2%$46.08m
LCILannett Company, Inc.
-4.53%4.8537.0%$8.90m
AKTXAkari Therapeutics Plc Sponsored ADR
4.12%1.771.7%$0.02m

Company Profile

XenoPort, Inc. operates as a biopharmaceutical company. Its products include horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and is headquartered in Atlanta, GA.